News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
746,417 Results
Type
Article (44672)
Company Profile (276)
Press Release (701453)
Multimedia
Podcasts (103)
Webinars (20)
Section
Business (208406)
Career Advice (2210)
Deals (36359)
Drug Delivery (135)
Drug Development (82886)
Employer Resources (179)
FDA (16802)
Job Trends (15277)
News (353273)
Policy (33493)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2721)
Academic (1)
Accelerated approval (49)
Adcomms (29)
Allergies (173)
Alliances (50726)
ALS (214)
Alzheimer's disease (1823)
Antibody-drug conjugate (ADC) (470)
Approvals (17193)
Artificial intelligence (681)
Autoimmune disease (304)
Automation (58)
Bankruptcy (366)
Best Places to Work (11783)
BIOSECURE Act (20)
Biosimilars (228)
Biotechnology (176)
Bladder cancer (200)
Brain cancer (76)
Breast cancer (766)
Cancer (5952)
Cardiovascular disease (488)
Career advice (1875)
Career pathing (46)
CAR-T (338)
CDC (63)
Celiac Disease (3)
Cell therapy (925)
Cervical cancer (48)
Clinical research (71965)
Collaboration (2099)
Company closure (5)
Compensation (1413)
Complete response letters (82)
COVID-19 (2827)
CRISPR (111)
C-suite (1159)
Cystic fibrosis (154)
Data (8061)
Decentralized trials (3)
Denatured (33)
Depression (167)
Dermatology (90)
Diabetes (597)
Diagnostics (7037)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (325)
Drug pricing (211)
Drug shortages (36)
Duchenne muscular dystrophy (287)
Earnings (92814)
Editorial (71)
Employer branding (22)
Employer resources (157)
Events (121770)
Executive appointments (1103)
FDA (20582)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1759)
Gene editing (239)
Generative AI (58)
Gene therapy (739)
GLP-1 (1096)
Government (4854)
Grass and pollen (7)
Guidances (411)
Healthcare (19414)
HIV (83)
Huntington's disease (58)
IgA nephropathy (99)
Immunology and inflammation (296)
Immuno-oncology (95)
Indications (196)
Infectious disease (3176)
Inflammatory bowel disease (225)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (294)
Interviews (357)
IPO (16823)
IRA (54)
Job creations (3792)
Job search strategy (1560)
JPM (59)
Kidney cancer (20)
Labor market (103)
Layoffs (575)
Leadership (42)
Legal (8146)
Liver cancer (101)
Longevity (33)
Lung cancer (784)
Lymphoma (435)
Machine learning (60)
Management (62)
Manufacturing (1070)
MASH (195)
Medical device (14127)
Medtech (14255)
Mergers & acquisitions (20812)
Metabolic disorders (1543)
mRNA (214)
Multiple sclerosis (192)
NASH (20)
Neurodegenerative disease (434)
Neuropsychiatric disorders (111)
Neuroscience (3379)
Neurotech (1)
NextGen: Class of 2026 (6688)
Non-profit (4676)
Now hiring (78)
Obesity (729)
Opinion (303)
Ovarian cancer (227)
Pain (260)
Pancreatic cancer (311)
Parkinson's disease (376)
Partnered (33)
Patents (600)
Patient recruitment (683)
Peanut (62)
People (60982)
Pharmaceutical (60)
Pharmacy benefit managers (35)
Phase 1 (22355)
Phase 2 (31696)
Phase 3 (23645)
Pipeline (8974)
Policy (334)
Postmarket research (2637)
Preclinical (9541)
Press Release (66)
Prostate cancer (314)
Psychedelics (59)
Radiopharmaceuticals (329)
Rare diseases (1104)
Real estate (6133)
Recruiting (73)
Regulatory (25961)
Reports (57)
Research institute (2499)
Resumes & cover letters (372)
Rett syndrome (39)
RNA editing (22)
RSV (93)
Schizophrenia (181)
Series A (292)
Series B (214)
Service/supplier (12)
Sickle cell disease (114)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (48)
Startups (3761)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (91)
The Weekly (68)
Vaccines (1135)
Venture capital (112)
Weight loss (474)
Women's health (128)
Worklife (22)
Date
Today (46)
Last 7 days (613)
Last 30 days (3315)
Last 365 days (30396)
2026 (13244)
2025 (30485)
2024 (35580)
2023 (40464)
2022 (51643)
2021 (56260)
2020 (54801)
2019 (47516)
2018 (35824)
2017 (32875)
2016 (32439)
2015 (38448)
2014 (32064)
2013 (27170)
2012 (29384)
2011 (30086)
2010 (28029)
Location
Africa (795)
Alabama (93)
Alaska (7)
Arizona (350)
Arkansas (14)
Asia (41247)
Australia (6838)
California (13442)
Canada (3816)
China (1388)
Colorado (572)
Connecticut (582)
Delaware (414)
Europe (90943)
Florida (2013)
Georgia (439)
Hawaii (3)
Idaho (63)
Illinois (1076)
India (92)
Indiana (622)
Iowa (23)
Japan (546)
Kansas (131)
Kentucky (50)
Louisiana (43)
Maine (76)
Maryland (1616)
Massachusetts (9598)
Michigan (372)
Minnesota (737)
Mississippi (6)
Missouri (148)
Montana (33)
Nebraska (29)
Nevada (146)
New Hampshire (84)
New Jersey (3528)
New Mexico (30)
New York (3520)
North Carolina (1711)
North Dakota (9)
Northern California (6751)
Ohio (401)
Oklahoma (24)
Oregon (41)
Pennsylvania (2703)
Puerto Rico (29)
Rhode Island (50)
South America (1170)
South Carolina (87)
South Dakota (2)
Southern California (5308)
Tennessee (218)
Texas (2144)
United States (47484)
Utah (400)
Vermont (1)
Virginia (330)
Washington D.C. (80)
Washington State (1072)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
746,417 Results for "22nd century group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
JCR Pharmaceuticals to Present at the 22nd Annual WORLDSymposium™ 2026
January 28, 2026
·
8 min read
Press Releases
Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium™
January 29, 2026
·
2 min read
Press Releases
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 10, 2026
·
8 min read
Press Releases
Zevra Therapeutics to Present Multiple Analyses on MIPLYFFA® at the 22nd Annual WORLDSymposium™
January 27, 2026
·
4 min read
Press Releases
Century Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
May 13, 2026
·
10 min read
Government
PhMRA’s long-standing leader Steve Ubl to leave lobby group by year-end
Industry leader Steve Ubl has served as PhRMA’s CEO for more than a decade, the longest tenure of any head of the trade group.
April 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™
February 5, 2026
·
7 min read
Press Releases
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
February 3, 2026
·
7 min read
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite these treatments.
February 27, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Century Therapeutics to Participate in Upcoming Investor Conferences in March 2026
February 25, 2026
·
1 min read
1 of 74,642
Next
